| Issue 1058: June 4, 2013 TOP STORIES
FEATURED RESOURCES JOURNAL ARTICLES AND NEWSLETTERS
CONFERENCES AND MEETINGS TOP STORIES Reminder: May issues of Needle Tips and Vaccinate Adults available online The May 2013 issues of Needle Tips and Vaccinate Adults are available online. Vaccinate Adults is an abbreviated version of Needle Tips with the pediatric content removed. Click on the images below to download the entire May 2013 issues (PDF) of Needle Tips and/or Vaccinate Adults.   Needle Tips: View the table of contents, magazine viewer, and back issues. Vaccinate Adults: View the table of contents, magazine viewer, and back issues. Back to top CDC publishes report on preventing unsafe injection practices in the U.S. healthcare system CDC published Preventing Unsafe Injection Practices in the U.S. Health-Care System in the May 31 issue of MMWR (pages 423–425). The first paragraph of the article is reprinted below. [Note: Published occasionally in MMWR, CDC Grand Rounds reports are based on grand rounds presentations made at CDC on high-profile issues in public health science, practice, and policy.] Injectable medicines commonly are used in health-care settings for the prevention, diagnosis, and treatment of various illnesses. Examples include chemotherapy, intravenous antibiotics, vaccinations, and medications used for sedation and anesthesia. Medical injections often are administered in conjunction with surgical procedures, endoscopy, imaging studies, pain control, and cosmetic or complementary and alternative medicine procedures. Safe manufacturing and pharmacy practices are essential because every injection must begin with sterile medication. The appropriate medication must then be safely prepared (typically drawn up in a syringe), then administered in a manner that maintains sterility and minimizes risk for infection. Safe administration depends on adherence to the practices outlined in CDC's evidence-based Standard Precautions guideline. Health-care providers should never (1) administer medications from the same syringe to more than one patient, (2) enter a vial with a used syringe or needle, or (3) administer medications from single-dose vials to multiple patients. They also should maintain aseptic technique at all times and properly dispose of used injection equipment. Related Links
ACOG publishes updated committee opinion regarding vaccinating pregnant women with Tdap vaccine The American College of Obstetricians and Gynecologists (ACOG) recently published Update on Immunization and Pregnancy: Tetanus, Diphtheria, and Pertussis Vaccination. Developed by ACOG’s Committee on Obstetric Practice, the updated opinion replaces an opinion on the same topic, which ACOG issued in 2012. The abstract of the June 2013 opinion is reprinted below. In the face of dramatic and persistent increases in pertussis disease in the United States, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices has updated its guidelines for the use of the tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) for pregnant women. The new guidance was issued based on an imperative to minimize the significant burden of pertussis disease in vulnerable newborns, the reassuring safety data on the use of Tdap in adults, and the evolving immunogenicity data that demonstrate considerable waning of immunity after immunization. The revised Advisory Committee on Immunization Practices guidelines recommend that health care personnel administer a dose of Tdap during each pregnancy, irrespective of the patient’s prior history of receiving Tdap. To maximize the maternal antibody response and passive antibody transfer and levels in the newborn, optimal timing for Tdap administration is between 27 weeks and 36 weeks of gestation, although Tdap may be given at any time during pregnancy. However, there may be compelling reasons to vaccinate earlier in pregnancy. There is no evidence of adverse fetal effects from vaccinating pregnant women with an inactivated virus or bacterial vaccines or toxoids, and a growing body of robust data demonstrates safety of such use. For women who previously have not received Tdap, if Tdap was not administered during pregnancy it should be administered immediately postpartum to the mother in order to reduce the risk of transmission to the newborn. Additionally, other family members and planned direct caregivers also should receive Tdap as previously recommended (sustained efforts at cocooning). Given the rapid evolution of data surrounding this topic, immunization guidelines are likely to change over time and the American College of Obstetricians and Gynecologists will continue to issue updates accordingly. Back to top IAC Spotlight! Ten vaccine-related slide set presentations available from IAC, CDC, and other trusted sources Looking for slides for an upcoming presentation on immunization? Look no further. The PowerPoint Presentations web section includes ten immunization-related slide sets from IAC, CDC, AAP, Autism Science Foundation, California Immunization Coalition, and WHO. Browse IAC’s collection of presentation slides for ideas and content for your next educational offering on improving immunization practices. They are posted in PDF format, and IAC's three slide sets are available in PowerPoint format by request. IAC recently updated this slide set: A Photo Collection of Vaccine-Preventable Diseases. To obtain any of IAC's three slide sets in PowerPoint format, simply request them from IAC by sending an email to admin@immunize.org. IAC’s Presentations section on immunization and vaccine-preventable diseases is part of IAC’s online Directory of Immunization Resources. Back to top FEATURED RESOURCES Order IAC's popular full-size laminated versions of the 2013 U.S. immunization schedules today! IAC's laminated versions of the 2013 U.S. child/teen and adult immunization schedules are covered with a tough, washable coating that lets them stand up to a year's worth of use in every area of your healthcare setting where immunizations are given. Each has six pages (i.e., three double-sided pages) and is folded to measure 8.5" by 11".  
PRICING 1–4 copies: $7.50 each 5–19 copies: $5.50 each 20–99 copies: $4.50 each 100–499 copies: $4.00 each 500–999 copies: $3.50 each For quotes on customizing or placing orders for 1,000 copies or more, call (651) 647-9009 or email admininfo@immunize.org You can access specific information on both schedules, view images of both, order online, or download an order form at the Shop IAC: Laminated Schedules web page. Back to top JOURNAL ARTICLES AND NEWSLETTERS May issue of CDC's Immunization Works newsletter now available CDC recently released the May issue of its monthly newsletter Immunization Works and posted it on the website of the National Center for Immunization and Respiratory Diseases (NCIRD). The newsletter offers the immunization community information about current topics. The information is in the public domain and can be reproduced and circulated widely. The May issue contains a great deal of useful, timely information. Be sure to read through all four sections: Top Stories, Influenza Information, Meetings and Conferences, and Resources and Information. Related Link
Back to top CDC's surveillance of U.S. health behavior includes information on influenza and pneumococcal vaccination On May 31, CDC published a surveillance summary titled Surveillance for Certain Health Behaviors Among States and Selected Local Areas—United States, 2010. The paragraphs on influenza vaccination and pneumococcal vaccination from the article's Preventive Practices section are reprinted below. Influenza Vaccination In 2010, the estimated prevalence of receiving an influenza vaccination among adults aged ≥65 years during the preceding 12 months at the state level ranged from 26.9% in Puerto Rico to 73.4% in Colorado (median: 67.4%) (Table 16). Among selected metropolitan and micropolitan statistical areas (MMSAs), the estimated prevalence ranged from 51.7% in Miami-Fort Lauderdale-Miami Beach, Florida, to 77.1% in Barre, Vermont (median: 67.9%) (Table 17). Among selected counties, the estimated prevalence ranged from 49.3% in Miami-Dade County, Florida, to 87.8% in Douglas County, Colorado (median: 68.6%) (Table 18). Pneumococcal Vaccination In 2010, the estimated prevalence of ever having received a pneumonia injection or pneumococcal vaccine among adults aged ≥65 years ranged from 24.7% in Puerto Rico to 74.0% in Oregon (median: 68.6%) (Table 19). Among selected MMSAs, the estimated prevalence ranged from 48.6% in Laredo, Texas, to 79.9% in Naples-Marco Island, Florida (median: 70.0%) (Table 20). Among selected counties, the estimated prevalence ranged from 47.6% in Hudson County, New Jersey, to 83.1% in Potter County, Texas (median: 70.6%) (Table 21). Back to top CONFERENCES AND MEETINGS Presentations from 2013 National Adult and Influenza Immunization Summit now online; winners of Immunization Excellence Awards announced The 2013 National Adult and Influenza Immunization Summit (NAIIS) was held in Atlanta on May 14–16. Slides of the presentations made at the summit are available. In addition, the National Influenza Vaccine Summit's 2013 Immunization Excellence Awards were presented during NAIIS. These prestigious awards recognize individuals and organizations that have made extraordinary contributions toward improving adult and/or childhood influenza vaccination rates within their communities during the 2012–2013 influenza season. Descriptions of the winning projects are available for review. Back to top  |
About IZ Express
IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer
ISSN 2771-8085
IZ Express Disclaimer
ISSN 2771-8085
Editorial Information
-
Editor-in-ChiefKelly L. Moore, MD, MPH
-
Managing EditorJohn D. Grabenstein, RPh, PhD
-
Associate EditorSharon G. Humiston, MD, MPH
-
Writer/Publication CoordinatorTaryn Chapman, MS
Courtnay Londo, MA -
Style and Copy EditorMarian Deegan, JD
-
Web Edition ManagersArkady Shakhnovich
Jermaine Royes -
Contributing WriterLaurel H. Wood, MPA
-
Technical ReviewerKayla Ohlde